Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Mouth Neoplasms × Photochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 8 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Basal Cell 3 Warts 1 Tongue Neoplasms 1 Sezary Syndrome 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Mycosis Fungoides 1 Mouth Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoid Interstitial Pneumonia 1 Leukoplakia, Oral 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Bowen's Disease 1 Basal Cell Nevus Syndrome 1 Barrett Esophagus 1

Interventions

Cisplatin 7 Cetuximab 6 Radiotherapy, Intensity-Modulated 4 pembrolizumab 3 durvalumab 3 Radiotherapy 2 Radiation 2 Observation 2 Drug Therapy 2 Celecoxib 2 Bupropion 2 130-nm albumin-bound paclitaxel 2 trametinib 1 sodium thiosulfate 1 gluconic acid 1 ficlatuzumab 1 Zinc 1 Watchful Waiting 1 Varenicline 1 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Tadalafil 1 Sirolimus 1 RRx-001 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Pilocarpine 1 Photochemotherapy 1 Periodontal Debridement 1 Oral Hygiene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03638622 2021-02-21

UH3-India

Massachusetts General Hospital

Phase 1/2 Completed

30 enrolled 4 charts

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡